Retrospective follow-up data on 458 consecutive patients who received a Hancock, Carpentier-Edwards (C-E) or Ionescu-Shiley (I-S) bioprosthesis in the aortic valve position between April 1978 and December 1981 are reviewed. A total of 461 valves (184 Hancock, 131 C-E and 146 I-S) were available for study of the incidence of primary tissue valve failure after 5 to 9 years of follow-up. Cumulative follow-up was 1,016 patient-years for patients with Hancock valve, 688 for the C-E and 767 for the I-S group. Of the 397 prostheses at risk (154 Hancock, 120 C-E and 123 I-S), 36 instances of primary tissue valve failure occurred (12 Hancock, 7 C-E and 17 I-S). On an actuarial basis, the calculated probability of freedom from primary tissue valve failure was 88 +/- 4% for the Hancock group, 87 +/- 6% for the C-E and 51 +/- 17% for the I-S at 9 years. The linear incidence of tissue valve failure was 1.2 failing valves per 100 patient-years for the Hancock group, 1 for the C-E and 2.2 for the I-S. In a cohort of patients older than 40 years of age at the time of valve replacement, the rate of freedom from primary failure was 98 +/- 1%, 87 +/- 9% and 44 +/- 22% for the Hancock, C-E and I-S groups, respectively, at 9 years. Comparison of actuarial curves disclosed a meaningful difference between the pericardial valve and the Hancock and C-E porcine bioprostheses at 9-year follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9149(88)91072-7 | DOI Listing |
The purpose of the present study was to evaluate and compare the clinical outcomes of two groups of patients subject to bi-cruciate retaining (BCR) or posterior-stabilized (PS) implants. It was hypothesized that patients treated with BCR prostheses would present higher flexion and better clinical and functional results than those treated with PS implants. This prospective study included thirty-two patients treated for primary knee osteoarthritis and assigned to two matched groups for their demographic characteristics and comorbidities.
View Article and Find Full Text PDFFront Immunol
January 2025
Faculty of Life and Biotechnology, Kunming University of Science and Technology, Kunming, China.
Background: Dysbiosis of the lung microbiome can contribute to the initiation and progression of lung cancer. Synchronous multiple primary lung cancer (sMPLC) is an increasingly recognized subtype of lung cancer characterized by high morbidity, difficulties in early detection, poor prognosis, and substantial clinical challenges. However, the relationship between sMPLC pathogenesis and changes in the lung microbiome remains unclear.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
January 2025
Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, United States.
Recombinant human IGF-1 is used to treat severe primary IGF-1 deficiency, but this treatment requires twice-daily injection, often does not fully correct the growth deficit, and has important off-target effects. We therefore sought to target IGF-1 to growth plate cartilage by generating fusion proteins combining IGF-1 with single-chain human antibody fragments that target matrilin-3, a cartilage matrix protein. We previously showed that this cartilage-targeting IGF-1 fusion protein (CV1574-1) promoted growth plate function in a GH-deficient (lit) mouse model.
View Article and Find Full Text PDFTzu Chi Med J
September 2024
School of Medicine, Tzu Chi University, Hualien, Taiwan.
Objectives: Gastric cancer (GC) is one of the most malignant tumors. Mounting studies highlighted gastric cancer stem cells (GCSCs) were responsible for the failure of treatment due to recurrence and drug resistance of advanced GC. However, targeted therapy against GCSC for improving GC prognosis suffered from lack of suitable models and molecular targets in terms of personalized medicine.
View Article and Find Full Text PDFFront Plant Sci
January 2025
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Maize () is India's third-largest grain crop, serving as a primary food source for at least 30% of the population and sustaining 900 million impoverished people globally. The growing human population has led to an increasing demand for maize grains. However, maize cultivation faces significant challenges due to a variety of environmental factors, including both biotic and abiotic stresses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!